L871-1024 Screening compound: N-({5-[(3-ethoxy-2-hydroxyphenyl)methyl]-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)-N-phenylacetamide

L871-1024 Screening compound: N-({5-[(3-ethoxy-2-hydroxyphenyl)methyl]-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)-N-phenylacetamide
L871-1024 Screening compound: N-({5-[(3-ethoxy-2-hydroxyphenyl)methyl]-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L871-1024
N-({5-[(3-ethoxy-2-hydroxyphenyl)methyl]-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L871-1024

Molecular Formula

C25H30N4O3 (C25 H30 N4 O3)

Compound Name

N-({5-[(3-ethoxy-2-hydroxyphenyl)methyl]-1-methyl-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-3-yl}methyl)-N-phenylacetamide

IUPAC name

N-({5-[(3-ethoxy-2-hydroxyphenyl)methyl]-1-methyl-1H4H5H6H7H-pyrazolo[43-c]pyridin-3-yl}methyl)-N-phenylacetamide

SMILES

CCOc1cccc(CN(CC2)Cc3c2n(C)nc3CN(C(C)=O)c2ccccc2)c1O

InChI

InChI=1S/C25H30N4O3/c1-4-32-24-12-8-9-19(25(24)31)15-28-14-13-23-21(16-28)22(26-27(23)3)17-29(18(2)30)20-10-6-5-7-11-20/h5-12,31H,4,13-17H2,1-3H3

InChI Key

RQMPFNJYPZYXMS-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31993158

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.54

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

2.889

Distribution Coefficient, logD

-3.299

Water Solubility, LogSw

-3.11

Polar Surface Area

57.926

Acid Dissociation Constant (pKa)

10.50

Base Dissociation Constant (pKb)

14.20

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

36.00

L871-1024 in Drug Discovery

Included in Screening Libraries

Bromodomain Modulators Library (5801 compounds)

KRAS-Targeted Library (16000 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetics of Beta-Turn Motifs Library (2153 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with L871-1024 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L871-1024?
Check Price and Availability of L871-1024, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L871-1024 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L871-1024
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L871-1024
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L871-1024 available by request